Evidence map›Paper›PMID 25432777›Full record

ArticleMolecular systems biology2014

Potential of fecal microbiota for early-stage detection of colorectal cancer.

Georg Zeller, Julien Tap, Anita Y Voigt, Shinichi Sunagawa, Jens Roat Kultima, Paul I Costea, Aurélien Amiot, Jürgen Böhm, Francesco Brunetti, Nina Habermann and 16 more

3 registry-linked trialsOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Molecular systems biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 787 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
787citing papers in PubMed, 7 pooled it
24.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02328677 recruitingnot on this map

ColoCare Transdisciplinary Research in Colorectal Cancer Prognosis

TypeobservationalSponsorUniversity of UtahRan2007 to 2030Enrolled5,000ConditionsColorectal Cancer
NCT06588166 recruitingnot on this mapstarted 2024, after this paper: background citation

A Non-invasive Gut Microbiome-based Diagnostic Tool for the Screening of Colorectal Cancer

TypeobservationalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2024 to 2027Enrolled1,006ConditionsColorectal CancerArmsGut microbiome testing
NCT06738173 recruitingnot on this mapstarted 2025, after this paper: background citation

A Gut Microbiome-based Diagnostic Tool for the Screening of Colorectal Cancer

TypeobservationalSponsorCatholic University of the Sacred HeartRan2025 to 2029Enrolled1,202ConditionsColorectal CancerArmsGut microbiome testing
3 · Its place in the literature

Who cites it

787 citing papers in PubMed, 7 syntheses or guidelines pooled it, 1,407 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Review
  10. Gut microbes · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Gut Microbial Topology and Metabolic Signatures Associated With Colorectal Neoplasia.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Innovatively Unlocking Anammox Driven by Nitrite Accumulation in a nrfA-Deficient Shewanella oneidensis MR-1 Consortium.Water environment research : a research publication of the Water Environment Federation · 2026
    Article
  20. Review

727 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 6 institutions in 4 countries.

Georg ZellerStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Julien TapStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany Department of Gastroenterology and LIC-EA4393-EC2M3, APHP and UPEC Université Paris-Est Créteil, Créteil, France.
Anita Y VoigtStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany Department of Applied Tumor Biology, Institute of Pathology University Hospital Heidelberg, Heidelberg, Germany Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg and European Molecular Biology Laboratory, Heidelberg, Germany.
Shinichi SunagawaStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Jens Roat KultimaStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Paul I CosteaStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Aurélien AmiotDepartment of Gastroenterology and LIC-EA4393-EC2M3, APHP and UPEC Université Paris-Est Créteil, Créteil, France.
Jürgen BöhmDivision of Preventive Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany German Cancer Research Center (DKFZ), Heidelberg, Germany.
Francesco BrunettiDepartment of Surgery, APHP and UPEC Université Paris-Est Créteil, Créteil, France.
Nina HabermannDivision of Preventive Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rajna HercogGenomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.
Moritz KochDepartment of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Alain LucianiDepartment of Radiology, APHP and UPEC Université Paris-Est Créteil, Créteil, France.
Daniel R MendeStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
Martin A SchneiderDepartment of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Petra Schrotz-KingDivision of Preventive Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany German Cancer Research Center (DKFZ), Heidelberg, Germany.
Christophe TournigandDepartment of Medical Oncology, APHP and UPEC Université Paris-Est Créteil, Créteil, France.
Jeanne Tran Van NhieuDepartment of Pathology and LIC-EA4393-EC2M3, APHP and UPEC Université Paris-Est Créteil, Créteil, France.
Takuji YamadaDepartment of Biological Information, Tokyo Institute of Technology, Tokyo, Japan.
Jürgen ZimmermannGenomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.
Vladimir BenesGenomics Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany.
Matthias KloorDepartment of Applied Tumor Biology, Institute of Pathology University Hospital Heidelberg, Heidelberg, Germany Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg and European Molecular Biology Laboratory, Heidelberg, Germany.
Cornelia M UlrichDivision of Preventive Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany German Cancer Research Center (DKFZ), Heidelberg, Germany Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA, USA.
Magnus von Knebel DoeberitzDepartment of Applied Tumor Biology, Institute of Pathology University Hospital Heidelberg, Heidelberg, Germany Clinical Cooperation Unit Applied Tumor Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg and European Molecular Biology Laboratory, Heidelberg, Germany.
Iradj SobhaniDepartment of Gastroenterology and LIC-EA4393-EC2M3, APHP and UPEC Université Paris-Est Créteil, Créteil, France iradj.sobhani@hmn.aphp.fr bork@embl.de.
Peer BorkStructural and Computational Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany Molecular Medicine Partnership Unit (MMPU), University Hospital Heidelberg and European Molecular Biology Laboratory, Heidelberg, Germany Max Delbrück Centre for Molecular Medicine, Berlin, Germany iradj.sobhani@hmn.aphp.fr bork@embl.de.
European Molecular Biology Laboratory · DEGerman Cancer Research Center · DEUniversité Paris-Est Créteil · FRHeidelberg University · DEMax Delbrück Center · DETokyo Institute of Technology · JP

Funding

Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare StudyU01CA206110 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jane C. Figueiredo, Christopher I Li · 2016 to 2026
$18.6M
European Research Council 268985NCI NIH HHS U01 CA206110
6 · The paper itself

Abstract

Several bacterial species have been implicated in the development of colorectal carcinoma (CRC), but CRC-associated changes of fecal microbiota and their potential for cancer screening remain to be explored. Here, we used metagenomic sequencing of fecal samples to identify taxonomic markers that distinguished CRC patients from tumor-free controls in a study population of 156 participants. Accuracy of metagenomic CRC detection was similar to the standard fecal occult blood test (FOBT) and when both approaches were combined, sensitivity improved > 45% relative to the FOBT, while maintaining its specificity. Accuracy of metagenomic CRC detection did not differ significantly between early- and late-stage cancer and could be validated in independent patient and control populations (N = 335) from different countries. CRC-associated changes in the fecal microbiome at least partially reflected microbial community composition at the tumor itself, indicating that observed gene pool differences may reveal tumor-related host-microbe interactions. Indeed, we deduced a metabolic shift from fiber degradation in controls to utilization of host carbohydrates and amino acids in CRC patients, accompanied by an increase of lipopolysaccharide metabolism.

Indexed as

Case-Control StudiesColorectal NeoplasmsEarly Detection of CancerFecesHumansMetagenomicsMicrobiotaMolecular TypingOccult BloodSensitivity and Specificitycancer screeningcolorectal cancerfecal biomarkershuman gut microbiomemetagenomics

Identifiers

PMID25432777
PMCPMC4299606
OpenAlexW2130725058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.